Structural Network Alterations Induced by ART-naive and ART-treated Subjects Infected with HIV
Abstract BackgroundTo investigate how the structural connectivity altered in cART-treated HIV patients and cART-naïve HIV patients by conducting Network analysis of Diffusion Tensor Imaging (DTI) data.MethodsWe enrolled 22 cART-naïve, 23 cART-treated and 28 normal controls in our current study. Firstly, the DTI imaging data pre-processing was conducted and the asymmetric 90 × 90 matrix for each participant from their DTI data was obtained with the use of PANDA. Then, we applied a graph-theoretical network analysis toolkit, GRETNA v2.0, to calculate metrics such as small-“worldness,” characteristic path length, clustering coefficient, global efficiency, local efficiency, and nodal “betweenness”. Finally, we took comparisons among the three groups to investigate topological alterations, and we also conducted relevant analysis with current CD4 T cell counts and neuropsychological evaluation.ResultsResults (1) the regional characteristics (nodal efficiency) were altered in CART- and CART+ patients predominantly in the frontal cortical regions; (2) changes in various network properties in CART- and CART+ patients were associated with the performance of behavior functions; (3) Reduced network segregation was associated with lower current CD4 count in cART- participants, suggesting that brain network segregation may be adversely affected by a history of greater immune suppression. (4) Hubs redistributed in HIV subjects especially in cART+ patients. Conclusion1) The regional characteristics (nodal efficiency) were altered in cART-naïve and cART-treated patients predominantly in the frontal cortical regions; (2) changes in various network properties in cART-naïve and cART-treated patients were associated with the performance of behavior functions; (3) reduced network segregation was associated with lower current CD4 count in cART-naïve participants, suggesting that brain network segregation may have been adversely affected by a history of greater immune suppression. (4) Hubs redistributed in HIV subjects especially in cART-treated patients.